Literature DB >> 9451722

Relationship between EEG reactivity and neuropsychological tests in vascular dementia.

J Partanen1, H Soininen, E L Helkala, M Könönen, R Kilpeläinen, P Riekkinen.   

Abstract

17 patients with vascular dementia (VaD) representing moderate to severe stage of the disease and 11 age-matched control subjects were examined with spectral analysis of EEG and a neuropsychological test battery comprising visual, praxic, verbal and memory functions as well as Mini-Mental Status test. VaD patients did not have less activity in the alpha band than control subjects, but the alpha amplitude ratio between eyes closed (EC) and eyes open (EO) situations (EC/EO ratio) was decreased in VaD patients, compared to controls. In VaD the variables of the awake background EEG with eyes closed (amplitude of alpha, beta, theta and delta activity; mean frequency) had only a few correlations to neuropsychological test scores. However, the (EC)/(EO) alpha ratio showed significant correlations with several neuropsychological variables in the temporo-occipital and centro-parietal derivations and some of these correlations were lateralized to the left or right hemisphere. Frontal EEG derivations with less alpha activity did not reveal any correlations to neuropsychological variables. We conclude that the dynamic EC/EO alpha ratio variable may be even more sensitive in the assessment of brain dysfunction in VaD than the background EEG variables.

Entities:  

Mesh:

Year:  1997        PMID: 9451722     DOI: 10.1007/BF01285558

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  18 in total

1.  Aging brain, aging mind.

Authors:  D J Selkoe
Journal:  Sci Am       Date:  1992-09       Impact factor: 2.142

2.  Topographical display and interpretation of event-related desynchronization during a visual-verbal task.

Authors:  G Pfurtscheller; W Klimesch
Journal:  Brain Topogr       Date:  1990       Impact factor: 3.020

3.  Longitudinal EEG spectral analysis in early stage of Alzheimer's disease.

Authors:  H Soininen; J Partanen; V Laulumaa; E L Helkala; M Laakso; P J Riekkinen
Journal:  Electroencephalogr Clin Neurophysiol       Date:  1989-04

4.  The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects.

Authors:  G Blessed; B E Tomlinson; M Roth
Journal:  Br J Psychiatry       Date:  1968-07       Impact factor: 9.319

5.  Drawing disability in patients with senile dementia.

Authors:  V Moore; M A Wyke
Journal:  Psychol Med       Date:  1984-02       Impact factor: 7.723

6.  Transformations towards the normal distribution of broad band spectral parameters of the EEG.

Authors:  T Gasser; P Bächer; J Möcks
Journal:  Electroencephalogr Clin Neurophysiol       Date:  1982-01

7.  Slow-wave activity in the spectral analysis of the electroencephalogram is associated with cortical dysfunctions in patients with Alzheimer's disease.

Authors:  E L Helkala; V Laulumaa; R Soikkeli; J Partanen; H Soininen; P J Riekkinen
Journal:  Behav Neurosci       Date:  1991-06       Impact factor: 1.912

8.  Quantitative topographical EEG compared to FDG PET for classification of vascular and degenerative dementia.

Authors:  B Szelies; R Mielke; K Herholz; W D Heiss
Journal:  Electroencephalogr Clin Neurophysiol       Date:  1994-08

9.  Pathological verification of ischemic score in differentiation of dementias.

Authors:  W G Rosen; R D Terry; P A Fuld; R Katzman; A Peck
Journal:  Ann Neurol       Date:  1980-05       Impact factor: 10.422

10.  EEG spectral analysis in vascular and Alzheimer dementia.

Authors:  M Signorino; E Pucci; N Belardinelli; G Nolfe; F Angeleri
Journal:  Electroencephalogr Clin Neurophysiol       Date:  1995-05
View more
  1 in total

1.  Changes in EEG spectral power in the prefrontal cortex of conscious rats elicited by drugs interacting with dopaminergic and noradrenergic transmission.

Authors:  C Sebban; X Q Zhang; B Tesolin-Decros; M J Millan; M Spedding
Journal:  Br J Pharmacol       Date:  1999-11       Impact factor: 8.739

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.